Australia-based startup Synchron planted its fifth brain-computer device and the first into the brain of a U.S. patient, emerging as a potential rival to Tesla Inc’s CEO Elon Musk’s Neuralink, which is yet to receive a regulatory nod.
What Happened
Doctors at the Mount Sinai West medical center in New York, on July 6, implanted Synchron’s first 1.5-inch device into the brain of an ALS (amyotrophic lateral sclerosis) patient, according to Bloomberg.Post recovery, it is hoped that the patient, who had lost the ability to move and speak, would be able to surf the internet and communicate via email and text simply by thinking.
